Pemphigus in Kuwait

International Journal of Dermatology

Volumn 38, Issue 5, 1999, Pages 351-356

  Alsaleh, Qasem A ^a   Nanda, Arti ^a   Al Baghli, Nazeeha M ^a   Dvorak, Richard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; PREDNISOLONE;

ACNE; ADOLESCENT; ADULT; AGED; ARAB; ARTICLE; BACTERIAL INFECTION; CANDIDIASIS; CHILD; CLINICAL FEATURE; CUSHINGOID SYNDROME; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; GASTRITIS; HAIR LOSS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KUWAIT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PEMPHIGUS; PEMPHIGUS VULGARIS; PYURIA; REMISSION; SIDE EFFECT; STEROID THERAPY; WEIGHT GAIN;

AGE OF ONSET; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZATHIOPRINE; CUSHING SYNDROME; CYCLOSPORINE; DAPSONE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KUWAIT; MALE; PEMPHIGUS; PREDNISOLONE; REMISSION INDUCTION; SEX FACTORS; SKIN; TIME FACTORS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0032999429     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1999.00664.x     Document Type: Article

References (23)

1. Lynch P, Gallego RE, Saied NK. Pemphigus: a review. Arizona Med 1976; 33: 1030-1037.
2. Diaz LA, Sampaio SAP, Rivitti EA, et al. Endemic pemphigus foliaceus (fogo selvagem): II. Current and historic epidemiologic studies. J Invest Dermatol 1989; 92: 4-12.
3. Iwatsuki K, Harada H, Zhang JZ, et al. Regulation of pemphigus and desmosomal antigen expression by keratinocyte differentiation. Dermatology 1994; 189 (Suppl. 1): 67-71.
4. Rappersberger K, Roos N, Stanley JR. Immunomorphologic and biochemical identification of the pemphigus foliaceus antigen with desmosomes. J Invest Dermatol 1992; 99: 323-330.
5. Simon DG, Krutchkoff D, Kaslow RA, Zarbo R. Pemphigus in Hartford county, Connecticut, from 1972 to 1977. Arch Dermatol 1980; 116: 1035-1037.
6. Krain LS. Pemphigus - epidemiologic and survival characteristics of 59 patients, 1959-1973. Arch Dermatol 1974; 110: 862-865.
7. Hietanen J, Salo OP. Pemphigus: an epidemiological study of patients treated in Finnish hospitals between 1969 and 1978. Acta Derm Venereol (Stockh) 1982; 62: 491-496.
8. Naldi L, Bertoni M, Cainelli T. Feasibility of a registry of pemphigus in Italy: two years experience, Int J Dermatol 1993; 32: 424-427.
9. Wilson C, Wojnarowska F, Mehra NK, Pasricha JS. Pemphigus in Oxford, UK, and New Delhi, India: a comparative study of disease characteristics and HLA antigens. Dermatology 1994; 189 (Suppl. 1): 108-110.
10. Bastuji-Garin S, Souissi R, Blum L, et al. Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women. J Invest Dermatol 1995; 104: 302-305.
11. Adam BA. Bullous diseases in Malaysia: epidemiology and natural history. Int J Dermatol 1992; 31: 42-45.
12. Pasricha JS, Thanzama J, Khan UK. Intermittent high dose dexamethasone cyclophosphamide therapy for pemphigus. Br J Dermatol 1988; 119: 73-77.
13. Park MS, Teraski PI, Ahmed AR, Tiwari JL. HLA DRW in 91% of Jewish pemphigus vulgaris patients. Lancet 1979; ii: 441-442.
14. Rosenberg FR, Sanders S, Nelson CT. Pemphigus a 20 year review of 107 patients treated with corticosteroids. Arch Dermatol 1976; 112: 962-970.
15. Pye RJ. Bullous eruptions. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology, 5th edn. Oxford: Blackwell Scientific Publications 1992: 1638.
16. Mashkilleyson K, Mashkilleyson AL. Mucous membrane manifestations of pemphigus vulgaris. Acta Derm Venereol 1988; 68: 413-421.
17. Seidenbaum M, David M, Saudbank M. The course and prognosis of pemphigus. A review of 115 patients. Int J Dermatol 1988; 27: 580-584.
18. Piamphongrant T, Ophaswongse S. Treatment of pemphigus. Int J Dermatol 1992; 31: 42-45.
19. Kyriakis KP, Vaseltzidis AG, Tosca AD. Environmental factors influencing the biologic behavior of patterns of pemphigus vulgaris: epidemiologic approach. Int J Dermatol 1995; 34: 181-185.
20. Korman M. Pemphigus. J Am Acad Dermatol 1988; 18: 1219-1238.
21. Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus. An update. Arch Dermatol 1996; 132: 203-212.
22. Huilgol SC, Black MM. Management of the immunobullous disorders. II. Pemphigus. Clin Exp Dermatol 1995; 20: 283-293.
23. Carson PJ, Hameed A, Ahmed AR. Influence of treatment on the clinical course of pemphigus. J Am Acad Dermatol 1996; 34: 645-652.